메뉴 건너뛰기




Volumn 21, Issue 3, 2010, Pages 144-150

Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3′-untranslated region of the PAI-1 gene and its pharmacologic implications

Author keywords

Cardiovascular risk; Insulin; Liver; Metabolic syndrome; Oxidative stress; Plasminogen activator inhibitor 1; Statins; Thrombosis

Indexed keywords

INSULIN; LUCIFERASE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIMVASTATIN;

EID: 77951295055     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328335790e     Document Type: Article
Times cited : (14)

References (27)
  • 1
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • VADT Investigators
    • VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360:129-139.
    • (2009) N Engl J Med , vol.360 , pp. 129-139
  • 2
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • ADVANCE Collaborative Group
    • ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
  • 3
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • ACCORD Study Group
    • ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-2559
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
  • 4
    • 0028008336 scopus 로고
    • Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
    • McGill JB, Schneider DJ, Arfken CL, Lucore LC, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994; 43:104-109.
    • (1994) Diabetes , vol.43 , pp. 104-109
    • McGill, J.B.1    Schneider, D.J.2    Arfken, C.L.3    Lucore, L.C.4    Sobel, B.E.5
  • 5
    • 44949088433 scopus 로고    scopus 로고
    • Metabolic syndrome, haemostasis and thrombosis
    • Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008; 99:995-1000.
    • (2008) Thromb Haemost , vol.99 , pp. 995-1000
    • Alessi, M.C.1    Juhan-Vague, I.2
  • 6
    • 33749052752 scopus 로고    scopus 로고
    • PAI-1 and the metabolic syndrome Links, causes, and consequences
    • Alessi M, Juhan-Vague I. PAI-1 and the metabolic syndrome. Links, causes, and consequences. Arterioscler Thromb Vasc Biol 2006; 26:2200-2207.
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 2200-2207
    • Alessi, M.1    Juhan-Vague, I.2
  • 7
    • 2942530422 scopus 로고    scopus 로고
    • Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription
    • Vulin AJ, Stanley FM. Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem 2004; 279:25172-25178.
    • (2004) J Biol Chem , vol.279 , pp. 25172-25178
    • Vulin, A.J.1    Stanley, F.M.2
  • 8
    • 0022354051 scopus 로고
    • Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
    • Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313:1557-1563.
    • (1985) N Engl J Med , vol.313 , pp. 1557-1563
    • Hamsten, A.1    Wiman, B.2    De Faire, U.3    Blomback, M.4
  • 9
    • 3242749003 scopus 로고    scopus 로고
    • Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type-1 (PAI-1)
    • Schneider DJ, Hayes M, Wadsworth M, Taatjes H, Rincon M, Taatjes DJ, Sobel BE. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type-1 (PAI-1). J Histochem Cytochem 2004; 52:1091-1099.
    • (2004) J Histochem Cytochem , vol.52 , pp. 1091-1099
    • Schneider, D.J.1    Hayes, M.2    Wadsworth, M.3    Taatjes, H.4    Rincon, M.5    Taatjes, D.J.6    Sobel, B.E.7
  • 10
    • 0033580594 scopus 로고    scopus 로고
    • Increased plasminogen activator inhibitor-1 and vasculopathy: A reconcilable paradox
    • Sobel BE. Increased plasminogen activator inhibitor-1 and vasculopathy: a reconcilable paradox. Circulation 1999; 99:2496-2498.
    • (1999) Circulation , vol.99 , pp. 2496-2498
    • Sobel, B.E.1
  • 11
    • 58149109143 scopus 로고    scopus 로고
    • Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1
    • Sato Y, Dong J, Imagawa S, Ishimori N, Furumoto T, Tsutsui H, et al. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1. Coron Artery Dis 2008; 19:355-361.
    • (2008) Coron Artery Dis , vol.19 , pp. 355-361
    • Sato, Y.1    Dong, J.2    Imagawa, S.3    Ishimori, N.4    Furumoto, T.5    Tsutsui, H.6
  • 12
    • 0036785795 scopus 로고    scopus 로고
    • Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes
    • Delbosc S, Morena M, Djouad F, Ledoucen C, Descomps B, Cristol JP. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J Cardiovasc Pharmacol 2002; 40:611-617.
    • (2002) J Cardiovasc Pharmacol , vol.40 , pp. 611-617
    • Delbosc, S.1    Morena, M.2    Djouad, F.3    Ledoucen, C.4    Descomps, B.5    Cristol, J.P.6
  • 14
    • 20944447650 scopus 로고    scopus 로고
    • Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/Enhancer-binding protein-d
    • Dong J, Fujii S, Li H, Nakabayashi H, Sakai M, Nishi S, et al. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/Enhancer-binding protein-d. Arterioscler Thromb Vasc Biol 2005; 25:1078-1084.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , pp. 1078-1084
    • Dong, J.1    Fujii, S.2    Li, H.3    Nakabayashi, H.4    Sakai, M.5    Nishi, S.6
  • 15
    • 0023937182 scopus 로고
    • Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences
    • Bosma PJ, van den Berg EA, Kooistra T, Siemieniak DR, Slightom JL. Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences. J Biol Chem 1988; 263:9129-9141.
    • (1988) J Biol Chem , vol.263 , pp. 9129-9141
    • Bosma, P.J.1    Van Den Berg, E.A.2    Kooistra, T.3    Siemieniak, D.R.4    Slightom, J.L.5
  • 16
    • 0027312110 scopus 로고
    • Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA
    • Fattal PG, Billadello JJ. Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA. Nucleic Acids Res 1993; 21:1463-1466.
    • (1993) Nucleic Acids Res , vol.21 , pp. 1463-1466
    • Fattal, P.G.1    Billadello, J.J.2
  • 17
    • 0025827561 scopus 로고
    • Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type 1: Implications for vascular disease in hyperinsulinemic states
    • Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type 1: implications for vascular disease in hyperinsulinemic states. Proc Natl Acad Sci U S A 1991; 88:9959-9963.
    • (1991) Proc Natl Acad Sci U S A , vol.88 , pp. 9959-9963
    • Schneider, D.J.1    Sobel, B.E.2
  • 18
    • 0026651718 scopus 로고
    • Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells
    • Schneider DJ, Nordt TK, Sobel BE. Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes 1992; 41:890-895.
    • (1992) Diabetes , vol.41 , pp. 890-895
    • Schneider, D.J.1    Nordt, T.K.2    Sobel, B.E.3
  • 19
    • 0026762333 scopus 로고
    • Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulinlike growth factor 1
    • Fattal PG, Schneider DJ, Sobel BE, Billadello JJ. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulinlike growth factor 1. J Biol Chem 1992; 267:12412-12415.
    • (1992) J Biol Chem , vol.267 , pp. 12412-12415
    • Fattal, P.G.1    Schneider, D.J.2    Sobel, B.E.3    Billadello, J.J.4
  • 20
    • 0034740869 scopus 로고    scopus 로고
    • The role of 30-untranslated region mediated mRNA stability in cardiovascular pathophysiology
    • Misquitta CM, Iyer VR,Werstiuk ES, Grover AK. The role of 30-untranslated region mediated mRNA stability in cardiovascular pathophysiology. Mol Cell Biochem 2001; 224:53-67.
    • (2001) Mol Cell Biochem , vol.224 , pp. 53-67
    • Misquitta, C.M.1    Iyer, V.R.2    Werstiuk, E.S.3    Grover, A.K.4
  • 21
    • 0038150766 scopus 로고    scopus 로고
    • Posttranscriptional regulation of PAI-1 gene expression
    • Heaton JH, Dlakic WM, Gelehrter TD. Posttranscriptional regulation of PAI-1 gene expression. Thromb Haemost 2003; 89:959-966.
    • (2003) Thromb Haemost , vol.89 , pp. 959-966
    • Heaton, J.H.1    Dlakic, W.M.2    Gelehrter, T.D.3
  • 22
    • 22144484438 scopus 로고    scopus 로고
    • Involvement of adenylyl cyclase signaling mechanism in insulin and IGF-I coregulation of fundamental cell processes
    • Pertseva MN. Involvement of adenylyl cyclase signaling mechanism in insulin and IGF-I coregulation of fundamental cell processes. Ann N Y Acad Sci 2005; 1040:429-430.
    • (2005) Ann N y Acad Sci , vol.1040 , pp. 429-430
    • Pertseva, M.N.1
  • 23
    • 33846991976 scopus 로고    scopus 로고
    • Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase
    • Biswas S, Gupta MK, Chattopadhyay D, Mukhopadhyay CK. Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase. Am J Physiol Heart Circ Physiol 2007; 292:758-766.
    • (2007) Am J Physiol Heart Circ Physiol , vol.292 , pp. 758-766
    • Biswas, S.1    Gupta, M.K.2    Chattopadhyay, D.3    Mukhopadhyay, C.K.4
  • 24
    • 0242407768 scopus 로고    scopus 로고
    • Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis
    • Sobel BE, Taatjes DJ, Schneider DJ. Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23:1979-1989.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 1979-1989
    • Sobel, B.E.1    Taatjes, D.J.2    Schneider, D.J.3
  • 26
    • 63349106607 scopus 로고    scopus 로고
    • A profibrotic effect of plasminogen activator inhibitor type-1 in the heart
    • Zaman AT, French CJ, Schneider DJ, Sobel BE. A profibrotic effect of plasminogen activator inhibitor type-1 in the heart. Exp Biol Med (Maywood) 2009; 234:246-254.
    • (2009) Exp Biol Med (Maywood) , vol.234 , pp. 246-254
    • Zaman, A.T.1    French, C.J.2    Schneider, D.J.3    Sobel, B.E.4
  • 27
    • 0030480352 scopus 로고    scopus 로고
    • Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids
    • Schneider DJ, Sobel BE. Synergistic augmentation of expression of plasminogen activator inhibitor type-1 induced by insulin, very-low-density lipoproteins, and fatty acids. Coron Artery Dis 1996; 7:813-817.
    • (1996) Coron Artery Dis , vol.7 , pp. 813-817
    • Schneider, D.J.1    Sobel, B.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.